Neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) are among the most promising candidates for distinguishing AKI subtypes. This evidence concerns the gene LCN2 and acute kidney injury.